Granules India Q1 FY27 Revenue Up 22% to ₹1,477 Cr
Granules India Limited reported its strongest first quarter ever for FY27, with revenue growing 22% year-on-year to INR 1,477 crores. EBITDA increased by 37% to INR 339 crores, and profit after tax surged by 60% to INR 180 crores. The company highlighted a significant improvement in its return on capital to 18% and a near-zero net debt to EBITDA ratio of 0.07x, indicating a virtually debt-free status. Operating cash generated was over INR 387 crores. The company also provided an update on its Gagillapur facility, stating that remediation work is essentially complete, with the FDA having raised no concerns on corrective actions. Seven out of eight facilities now have a clean EIR, and 9 applications are ready for launch pending FDA clearance.
Key Highlights
- Q1 FY27 revenue grew 22% YoY to ₹1,477 Cr.
- EBITDA up 37% to ₹339 Cr; PAT up 60% to ₹180 Cr.
- Return on capital improved to 18%; net debt to EBITDA at 0.07x.
- Remediation work at Gagillapur facility is essentially complete.
- Nine applications are ready for launch pending FDA clearance.
Price Impact
More from GRANULES